# Moderna and Lonza collaborate to manufacture COVID-19 vaccine

Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna's mRNA vaccine (mRNA-1273) against the novel coronavirus and additional Moderna products in the future.

- Type: Partnership
- Announced: 2020-05-05
- Status: announced
- Products: mRNA vaccine (mRNA-1273)
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Lonza Group AG](https://endata.com/companies/20735.md) (partner)
- [Moderna](https://endata.com/companies/47621.md) (partner)

## Sources

- [socma.org](https://www.socma.org/tag/socma-member-news/page/27/), 2020-06-02: "Moderna, Inc. and Lonza Ltd. today announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna's mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2) and additional Moderna products in the future."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.